MAPT and Alzheimer disease: AD is a neurodegenerative disease characterized by progressive memory deficits and cognitive decline [42], together with Aβ deposition, tau hyperphosphorylation, elevated oxidative stress and neuroinflammation, mitochondrial dysfunction, synaptic loss, and neurodegeneration in the brain [43].